LEO Pharma appoints new executive vice president

pharmafile | February 29, 2012 | Appointment | Business Services, Manufacturing and Production, Research and Development, Sales and Marketing LEO Pharma, supply chain 

From March Anders Spohr will take over the position of executive vice president for global product supply at LEO Pharma.

Spohr was only recently appointed senior vice president of LEO Pharma but soon will assume his new position overseeing LEO Pharma’s global production.

From his previous career with Novo Nordisk and Novozymes, Spohr has gained extensive experience in managing and governing global production. As executive vice president of global product supply, it will be his task to ensure flexible, efficient and streamlined production processes to support LEO Pharma’s operations in more than 100 countries worldwide.

Spohr worked for Novo Nordisk from 1997 to 2000, when he started working for Novozymes, which at that point separated from Novo Nordisk to become a company in its own right. During his 11 years at Novozymes, Spohr was stationed for a period at the company’s offices in North Carolina, US. His latest position in Novozymes, before joining LEO Pharma, was vice president of supply chain management.

Spohr takes over the position as executive vice president from John Mehlbye, who is retiring but will be on the LEO Foundation board. 

Related Content

money-pills-pharma-file

LEO Pharma to acquire Timber Pharmaceuticals for up to $36m

Timber Pharmaceuticals has announced that it has entered a definitive agreement to be acquired by …

dermatitis2015_-_copy

LEO Pharma’s delgocitinib hits main goals in moderate-to-severe chronic hand eczema

LEO Pharma has revealed new Phase 2b at the European Academy of Dermatology and Venereology …

medical-supplies-paper-bag

Medicines recalled after FMD alert

The MHRA has warned patients that batches of drugs for Parkinson’s, epilepsy and blood clots …

Latest content